文献速递重症综合管理与镇静镇痛

晚期脓毒症患者髓源性抑制细胞的单细胞RNA测序揭示多个亚群及独特转录反应:一项先导研究

Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study.
PubMed 文献 · Shock · 2021-01-01
一句话结论先导研究显示晚期脓毒症患者髓源性抑制细胞维持免疫抑制性转录谱,且转录组景观部分取决于原发脓毒症打击。

该先导研究对2例脓毒症后第21天的晚期脓毒症患者和2例对照者的全血髓系富集与Ficoll富集外周血单个核细胞混合物行CITE-seq。成功鉴定出粒细胞型、单核细胞型和早期型三个髓源性抑制细胞亚群簇;脓毒症与第21天时粒细胞型较单核细胞型髓源性抑制细胞相对扩增更明显相关。基因组分析揭示粒细胞型和单核细胞型亚群存在细胞特异性和共同的差异表达基因,许多共同基因既往与髓源性抑制细胞增殖和免疫抑制功能相关;有趣的是,文献中证明对肿瘤诱导的髓源性抑制细胞免疫抑制至关重要的若干基因未见差异表达。结论认为晚期脓毒症中髓源性抑制细胞维持免疫抑制性转录谱,慢性危重症中的景观部分依赖于原发脓毒症打击,且晚期脓毒症患者的免疫抑制性髓源性抑制细胞转录组似乎与肿瘤和/或其他炎症性疾病有所不同。

要点

  • 在2例脓毒症后第21天的晚期脓毒症患者和2例对照者中,单细胞RNA测序成功鉴定出粒细胞型、单核细胞型和早期型三个髓源性抑制细胞亚群簇。
  • 脓毒症与第21天时粒细胞型较单核细胞型髓源性抑制细胞相对扩增更明显相关,对照组无此表现。
  • 脓毒症患者与对照者之间,粒细胞型和单核细胞型髓源性抑制细胞亚群均存在细胞特异性和共同的差异表达基因,许多共同基因既往与髓源性抑制细胞增殖和免疫抑制功能相关。
  • 文献中证明对肿瘤诱导的髓源性抑制细胞免疫抑制至关重要的若干基因在晚期脓毒症中未见差异表达。
  • 晚期脓毒症患者的免疫抑制性髓源性抑制细胞转录组似乎与肿瘤和/或其他炎症性疾病有所不同。

适用人群与场景

  • 脓毒症后第21天的晚期脓毒症患者(2例)及对照者(2例),样本为全血髓系富集与Ficoll富集外周血单个核细胞的混合物。

研究设计与关键结果

  • 先导研究,采用CITE-seq对2例脓毒症后第21天患者和2例对照者的全血髓系富集与Ficoll富集外周血单个核细胞混合物进行单细胞RNA测序。
  • 成功鉴定出三个髓源性抑制细胞亚群簇:粒细胞型、单核细胞型和早期型。
  • 脓毒症与第21天时粒细胞型较单核细胞型髓源性抑制细胞相对扩增更明显相关,对照组无此表现。
  • 脓毒症患者与对照者之间,粒细胞型和单核细胞型髓源性抑制细胞亚群均存在细胞特异性和共同的差异表达基因,许多共同基因既往与髓源性抑制细胞增殖和免疫抑制功能相关。
  • 文献中证明对肿瘤诱导的髓源性抑制细胞免疫抑制至关重要的若干基因未见差异表达。

证据类型、等级与局限

  • 证据类型:先导研究(单细胞RNA测序)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,晚期脓毒症中髓源性抑制细胞维持免疫抑制性转录谱,慢性危重症中的景观部分依赖于原发脓毒症打击。
  • 作者认为,晚期脓毒症患者的免疫抑制性髓源性抑制细胞转录组似乎与肿瘤和/或其他炎症性疾病有所不同。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Increased circulating myeloid-derived suppressor cells (MDSCs) are independently associated with poor long-term clinical outcomes in sepsis. Studies implicate subsets of MDSCs having unique roles in lymphocyte suppression; however, characterization of these cells after sepsis remains incomplete. We performed a pilot study to determine the transcriptomic landscape in MDSC subsets in sepsis using single-cell RNAseq (scRNA-seq).

METHODS: A mixture of whole blood myeloid-enriched and Ficoll-enriched PBMCs from two late septic patients on post-sepsis day 21 and two control subjects underwent Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq).

RESULTS: We successfully identified the three MDSC subset clusters-granulocytic (G-), monocytic (M-), and early (E-) MDSCs. Sepsis was associated with a greater relative expansion of G-MDSCs versus M-MDSCs at 21 days as compared to control subjects. Genomic analysis between septic patients and control subjects revealed cell-specific and common differential expression of genes in both G-MDSC and M-MDSC subsets. Many of the common genes have previously been associated with MDSC proliferation and immunosuppressive function. Interestingly, there was no differential expression of several genes demonstrated in the literature to be vital to immunosuppression in cancer-induced MDSC.

CONCLUSION: This pilot study successfully demonstrated that MDSCs maintain a transcriptomic profile that is immunosuppressive in late sepsis. Interestingly, the landscape in chronic critical illness is partially dependent on the original septic insult. Preliminary data would also indicate immunosuppressive MDSCs from late sepsis patients appear to have a somewhat unique transcriptome from cancer and/or other inflammatory diseases.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Darden DB, Bacher R, Brusko MA, et al. Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study. Shock. 2021. PMID: 33021571. doi:10.1097/SHK.0000000000001671

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。